Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease 2”

353 trials

Showing 20 of 353 results

Large-scale testing (Phase 3)Looking for participantsNCT06989112
What this trial is testing

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Who this might be right for
Endometrial Cancer
AstraZeneca 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06431971
What this trial is testing

Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease

Who this might be right for
Parkinson Disease
InnoMedica Schweiz AG 40
Not applicableLooking for participantsNCT06617884
What this trial is testing

Home-based Gait and Balance Training in Patients With Movement Disorders

Who this might be right for
AtaxiaParkinson Disease
Forschungszentrum Juelich 80
Early research (Phase 1)Study completedNCT02054806
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)

Who this might be right for
Solid Tumor
Merck Sharp & Dohme LLC 477
Large-scale testing (Phase 3)UnknownNCT00724906
What this trial is testing

Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor

Who this might be right for
Parkinsonian Syndromes
Alseres Pharmaceuticals, Inc 240
Testing effectiveness (Phase 2)Study completedNCT03631407
What this trial is testing

Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)

Who this might be right for
Colorectal Neoplasms
Merck Sharp & Dohme LLC 41
Early research (Phase 1)Study completedNCT01964573
What this trial is testing

Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects

Who this might be right for
Parkinson's Disease
UCB Pharma 48
Testing effectiveness (Phase 2)Study completedNCT04928287
What this trial is testing

Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)

Who this might be right for
Parkinson Disease
Hope Biosciences Research Foundation 24
Not applicableStudy completedNCT00596908
What this trial is testing

123I-ALTROPANE® Reference Image Acquisition in Subjects With Diagnostically Uncertain Tremor

Who this might be right for
Upper Extremity Tremor
Alseres Pharmaceuticals, Inc 54
Early research (Phase 1)Study completedNCT02728947
What this trial is testing

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Luye Pharma Group Ltd. 28
Large-scale testing (Phase 3)Active Not RecruitingNCT03553836
What this trial is testing

Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 976
Early research (Phase 1)Study completedNCT03589066
What this trial is testing

Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Luye Pharma Group Ltd. 24
Large-scale testing (Phase 3)Study completedNCT01866319
What this trial is testing

Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 834
Large-scale testing (Phase 3)Active Not RecruitingNCT05899049
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 249
Testing effectiveness (Phase 2)Study completedNCT01294800
What this trial is testing

A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)

Who this might be right for
Parkinson's Disease
Merck Sharp & Dohme LLC 450
Testing effectiveness (Phase 2)Looking for participantsNCT07154511
What this trial is testing

Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

Who this might be right for
Parkinson DiseaseParkinson Disease Dementia
Prabesh Kanel 45
Testing effectiveness (Phase 2)Ended earlyNCT05709821
What this trial is testing

IMM60 and Pembrolizumab in Melanoma and NSCLC

Who this might be right for
Non-small Cell Lung CancerMelanoma
iOx Therapeutics 1
Testing effectiveness (Phase 2)Study completedNCT03284424
What this trial is testing

Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)

Who this might be right for
Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 159
Early research (Phase 1)Study completedNCT05594043
What this trial is testing

MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001)

Who this might be right for
Advanced or Metastatic Solid Tumors
Merck Sharp & Dohme LLC 90
Testing effectiveness (Phase 2)Study completedNCT00226460
What this trial is testing

Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

Who this might be right for
Parkinson's Disease
Genzyme, a Sanofi Company
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation